Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Autologous fat grafting to the breast is a widely used and accepted adjunct in breast reconstruction today. The technique involves harvest of fat from patient-specific donor sites, fat processing, and subsequent transfer in order to improve depressions and step-offs, which may exist at the junction of the reconstructed breast and chest wall, or following lumpectomy.
First introduced in 1895 by Czerny, fat grafting was utilized when an excised lipoma was transferred to the breast to reconstruct a breast defect. In the early 20 th century, fat grafting gained momentum, however the practice of fat grafting did not become popular until the 1980s. In 1987, however, the American Society of Plastic Surgeons (ASPS) banned autologous fat grafting of breasts over concern for future cancer surveillance in the setting of fat necrosis. In 2007, the ASPS established a task force to re-evaluate the potential hazards of fat grafting, and concluded that radiographic technology could distinguish grafted fat from potentially dangerous lesions. Therefore, the ASPS Fat Graft Task Force lifted the ban on fat grafting in 2009 when it determined from a limited number of studies that there appeared to be no interference with breast cancer detection.
Numerous recent studies have demonstrated the regenerative capabilities of transferred fat, including improved angiogenesis, dermal thickness and elasticity, and radiation-induced fibrotic changes. For this reason, fat grafting has become a useful adjunct and workhorse in lumpectomy defects as well as autologous and implant-based breast reconstruction, particularly in radiated fields.
Successful fat grafting requires close attention to the recipient site compliance and capacity, as well as thorough fat harvesting, processing, and delivery technique. Here, we discuss the current indications for autologous fat grafting as an adjunct in breast reconstruction and review pertinent aspects of the preoperative patient evaluation. We describe operative techniques including donor-site selection, fat harvesting and processing. We conclude with several case examples and a review of postoperative complications and their management.
Autologous fat grafting is indicated for the correction of contour deformities and step-offs following autologous or implant-based post-mastectomy breast reconstruction, which often occur at the periphery of the breast reconstruction. Transferred fat may also be utilized to improve the contour of lumpectomy defects. However, established and safe indications for autologous fat grafting vary by breast reconstruction modality.
In implant-based reconstruction, thin mastectomy flaps may lead to visible implant borders or implant rippling. Fat grafting may be utilized in these cases to camouflage implant rippling or smoothen the transition superiorly between the native chest wall and the implant. Fat grafting is commonly first performed at the time of tissue expander-to-implant exchange. However, in cases of direct implant reconstruction, fat grafting is often performed as a secondary procedure. It should be noted that patients may require several fat-grafting procedures in order to achieve desired results.
In autologous reconstruction, fat can be used to smoothen the transition (or “step-off”) between the flap and chest wall. Additionally, fat grafting has been described to augment the overall volume of smaller flaps or failed flaps. While fat grafting is more frequently performed approximately 3–6 months following flap transfer, some surgeons opt to fat graft potential flaps prior to free tissue transfer.
Fat grafting is a useful adjunct in the correction of contour abnormalities and breast asymmetry following lumpectomy. In the case of breast conservation therapy, a lumpectomy (or partial mastectomy) may be performed with adjuvant radiation therapy, where up to 30% of patients report dissatisfaction with aesthetic results. While radiated lumpectomy defects can represent a hostile environment, transferred fat has been shown to improve breast contour, as well as skin and soft tissue quality following radiation therapy thereby improving aesthetic outcomes. Again, patients may require more than one fat-grafting procedure in order to achieve desired results.
The only absolute contraindication to autologous fat grafting in breast reconstruction is lack of donor-site availability, which may be seen in an underweight patient. Additionally, patients with medical co-morbidities placing them at operative risk should not be offered fat grafting ( Box 20.1 ).
Mastectomy skin flap irregularities
Step-off at implant border
Implant rippling
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here